BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35116865)

  • 21. Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma.
    Wei Q; Li X; Zhu Z; Yu W; Qin G; Chen H; Gu Y; Zhao K; Fu X; Sun M
    Pathol Res Pract; 2019 Dec; 215(12):152645. PubMed ID: 31704154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy.
    Gao Z; Meng X; Mu D; Sun X; Yu J
    Oncol Lett; 2014 Apr; 7(4):1118-1122. PubMed ID: 24944678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of pathological tumor response and residual nodal metastasis in patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery.
    Oguma J; Ozawa S; Koyanagi K; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K
    Esophagus; 2019 Oct; 16(4):395-401. PubMed ID: 31190104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
    Leng X; He W; Yang H; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Liu H; Yang H; Li T; Zhang X; Li Q; Wang G; Mao T; Guo X; Lin T; Liu M; Fu J; Han Y
    Ann Surg; 2021 Dec; 274(6):e1022-e1029. PubMed ID: 31855875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant Therapeutic Modalities Following Three-field Lymph Node Dissection for Stage II/III Esophageal Squamous Cell Carcinoma.
    Li L; Zhao L; Lin B; Su H; Su M; Xie D; Jin X; Xie C
    J Cancer; 2017; 8(11):2051-2059. PubMed ID: 28819406
    [No Abstract]   [Full Text] [Related]  

  • 26. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
    Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
    Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of postoperative adjuvant chemotherapy for lymph node-positive esophageal squamous cell carcinoma: a propensity score matching analysis.
    Qin RQ; Wen YS; Wang WP; Xi KX; Yu XY; Zhang LJ
    Med Oncol; 2016 Apr; 33(4):31. PubMed ID: 26922662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis.
    Song J; Shi W; Zhang Y; Sun M; Liang X; Zheng S
    Onco Targets Ther; 2016; 9():6257-6263. PubMed ID: 27785073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma.
    Zhang W; Zhou Y; Li C; Xu S; Li M; Liu W; Ma Y; Wang H
    Anal Cell Pathol (Amst); 2020; 2020():2872479. PubMed ID: 33381388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.
    Jia J; Cui Y; Lu M; Wang X; Li J; Li J; Li Y; Zhang X; Gao J; Zhou J; Lu Z; Gong J; Yu J; Sun Z; Liu C; Shen L; Zhang X
    Clin Transl Oncol; 2016 Jun; 18(6):592-8. PubMed ID: 26459251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor receptor is a prognosis predictor in patients with esophageal squamous cell carcinoma.
    Zhang W; Zhu H; Liu X; Wang Q; Zhang X; He J; Sun K; Liu X; Zhou Z; Xu N; Xiao Z
    Ann Thorac Surg; 2014 Aug; 98(2):513-9. PubMed ID: 24881860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of different lymph node staging methods in esophageal squamous cell carcinoma after esophagectomy.
    Wu SG; Li FY; Zhou J; Lin Q; Sun JY; Lin HX; Guan XX; He ZY
    Ann Thorac Surg; 2015 Jan; 99(1):284-90. PubMed ID: 25440270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome.
    Xu YP; Lin G; Sun XJ; Yan MH; Zhang G; Hu JL; Sun WY; Yu JM
    J Cancer; 2016; 7(5):587-94. PubMed ID: 27053957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of vascular invasion and lymphatic invasion in predicting recurrent thoracic oesophageal squamous cell carcinoma.
    Ma Y; Yao X; Li Z; Chen J; Li W; Wang H; Zhang L; Zhu J
    World J Surg Oncol; 2022 Jan; 20(1):12. PubMed ID: 35012555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetic effect and molecular function of the SOCS5 in the prognosis of esophageal squamous cell carcinoma.
    Yang PW; Chang YH; Wong LF; Lin CC; Huang PM; Hsieh MS; Lee JM
    J Cancer; 2021; 12(8):2216-2229. PubMed ID: 33758600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
    Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
    Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.